4.7 Article

N-glycosylation of GDF15 abolishes its inhibitory effect on EGFR in AR inhibitor-resistant prostate cancer cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia

Jawed Akhtar Siddiqui et al.

Summary: Growth differentiation factor 15 or macrophage inhibitory cytokine-1 (GDF15/MIC-1) is a divergent member of the transforming growth factor beta superfamily and has diverse pathophysiological roles in cancers, cardiometabolic disorders, and other diseases. Its role in cancer development and progression is complicated and depends on the specific cancer type and stage, and its mechanisms are related to its receptor GFRAL.

CYTOKINE & GROWTH FACTOR REVIEWS (2022)

Review Biochemistry & Molecular Biology

PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects

Daniela Miricescu et al.

Summary: Breast cancer is a complex disease with various factors contributing to its pathogenesis. Current research is focused on the PI3K/AKT/mTOR signaling pathway and related cancer mutations. Clinical trials are also evaluating the efficacy of inhibitors targeting these signaling pathways in breast cancer treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemical Research Methods

The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression

Rebeca Kawahara et al.

Summary: The study utilizes glycomics and glycoproteomics to reveal unique N- and O-glycosylation features in prostate cancer (PCa) tissues, identifying their association with PCa progression. This provides new insights into the complexity and dynamics of the tissue glycoproteome associated with PCa progression, serving as an important resource for exploring the underlying disease mechanisms.

MOLECULAR & CELLULAR PROTEOMICS (2021)

Article Cell Biology

Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression

Sujun Chen et al.

Summary: Chen et al. conducted single-cell analysis to identify transcriptomic remodeling in various cell types that regulate prostate cancer progression. They found that the tumor microenvironment displayed activation of progression-associated transcriptomic programs and identified a subset of endothelial cells that actively communicate with tumor cells, promoting cancer cell invasion. Their study also revealed promiscuous KLK3 expression and the ability of cancer cells to alter T-cell transcriptomes.

NATURE CELL BIOLOGY (2021)

Article Medicine, General & Internal

Prostate cancer

Richard J. Rebello et al.

Summary: Prostate cancer is a prevalent disease among men, with key genetic alterations including gene fusions, oncogene amplification, and mutations in androgen receptors. Treatment options range from active surveillance to surgery and radiotherapy for localized disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Review Biochemistry & Molecular Biology

Interplay between orphan nuclear receptors and androgen receptor-dependent or-independent growth signalings in prostate cancer

Yuliang Wang et al.

Summary: Prostate cancer relies on the androgen receptor-mediated signaling for growth, making hormone or androgen-deprivation therapy a key treatment option. Despite its effectiveness in locally advanced or metastatic cases, most patients will develop resistance, leading to castration-resistant disease or even a more aggressive androgen-independent subtype. These newly identified orphan nuclear receptors (ONRs) have shown potential as biomarkers and therapeutic targets in advanced prostate cancer.

MOLECULAR ASPECTS OF MEDICINE (2021)

Review Urology & Nephrology

Resistance to second-generation androgen receptor antagonists in prostate cancer

Keith T. Schmidt et al.

Summary: The introduction of second-generation androgen receptor antagonists has revolutionized the treatment of metastatic prostate cancer, offering tolerable and effective alternatives to chemotherapy. However, the issue of treatment resistance remains a significant challenge, and researchers are exploring various approaches to address this issue.

NATURE REVIEWS UROLOGY (2021)

Review Endocrinology & Metabolism

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

Dongdong Wang et al.

Summary: Growth differentiation factor 15 (GDF15) expression is induced by cellular stress, metformin, and exercise. Its effects on food intake and inflammation are mediated through specific receptors and signaling pathways, making it a promising target for the treatment of metabolic diseases such as obesity and diabetes.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Article Multidisciplinary Sciences

2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer

Arnaud Blomme et al.

NATURE COMMUNICATIONS (2020)

Article Genetics & Heredity

The DNA methylation landscape of advanced prostate cancer

Shuang G. Zhao et al.

NATURE GENETICS (2020)

Article Biochemistry & Molecular Biology

High Mannose N-Glycans Promote Migration of Bone-Marrow-Derived Mesenchymal Stromal Cells

Vivian Alonso-Garcia et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Agriculture, Multidisciplinary

Comprehensive Analysis of the Glycome and Glycoproteome of Bovine Milk-Derived Exosomes

Wenyan Chen et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)

Review Genetics & Heredity

The relation between PI3K/AKT signalling pathway and cancer

Saeed Noorolyai et al.

Review Oncology

PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside

Ali S. Alzahrani

SEMINARS IN CANCER BIOLOGY (2019)

Article Medicine, Research & Experimental

Genomics of lethal prostate cancer at diagnosis and castration resistance

Joaquin Mateo et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Biochemistry & Molecular Biology

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

David A. Quigley et al.

Review Oncology

Glycosylation is a global target for androgen control in prostate cancer cells

Jennifer Munkley

ENDOCRINE-RELATED CANCER (2017)

Article Biochemistry & Molecular Biology

Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation

Changmin Peng et al.

MOLECULAR CELL (2017)

Article Biochemistry & Molecular Biology

The PI3K AKT pathway in the pathogenesis of prostate cancer

Xiaofei Wen

Frontiers in Bioscience-Landmark (2016)

Article Multidisciplinary Sciences

Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer

Yundong He et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

The mutational landscape of lethal castration-resistant prostate cancer

Catherine S. Grasso et al.

NATURE (2012)

Review Oncology

Growth/differentiation factor-15: prostate cancer suppressor or promoter?

P. Vanhara et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2012)

Article Endocrinology & Metabolism

Wild-Type p53 Attenuates Cancer Cell Motility by Inducing Growth Differentiation Factor-15 Expression

Jung-Chien Cheng et al.

ENDOCRINOLOGY (2011)

Article Biochemistry & Molecular Biology

A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

Sreenath V. Sharma et al.